All In MedTech

FDA Clearance Tracker · P080030-S016

GLAUKOS ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jul 21, 2015 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jul 21, 2015

Approved

Time to decision

60 days

Received May 22, 2015. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P080030-S016
Device name
GLAUKOS ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM
Applicant location
Laguna Hills, CA
Received
May 22, 2015
Decided
Jul 21, 2015
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Postapproval Study Protocol
Original approval
P080030

Device type

Device class
Class III
Specialty
Ophthalmology

Every decision under product code OGO

FDA's approval statement

As written in FDA's record.

APPROVAL OF CHANGES TO THE POST-APPROVAL STUDY PROTOCOL.

Source documents

Other decisions for Glaukos Corporation

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

1 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.